Esophageal cancer

Esophageal cancer is one of the most common types of malignant tumors. This disease is especially common in Asian countries such as Japan, North China and Iran. Increased incidence of esophageal cancer recorded in some parts of Siberia.

The risk of cancer is due to the peculiarities of traditional nutrition and cultural traditions of countries. The disease affects people from different age groups. Most often, esophageal cancer affects men, especially those aged 50-60 years.

Cancer of the esophagus is the most common oncological disease among all tumors of the gastrointestinal tract.

What is the esophagus and esophageal cancer?

The esophagus is a hollow tube in the chest that connects the oral cavity and pharynx to the stomach and consists of a mucous membrane (inner layer), a muscular layer and a connective tissue layer, or adventitia (outside). It is 25-30 cm long, starts in the neck (cervical part of the esophagus), passes through the posterior mediastinum (thoracic cavity) into the abdominal cavity (abdominal part), where it flows into the stomach.

Esophageal cancer develops from the epithelial cells of the esophageal mucosa. The neoplasm, as it grows, penetrates not only into the squamous epithelium, but also into the cells of other layers, and also spreads along. The gradual increase in neoplasm entails a narrowing of the lumen of the esophagus and blocks its functions. Most often, the tumor process occurs in the lower and middle parts of the esophagus.

Since the esophagus has a good lymphatic network, with the progression of the disease, cancer gives metastases, which first fall into the regional lymph nodes, and then into the distant ones.

Why does esophageal cancer occur?

This disease has a mixed nature of occurrence. The pathological process can be triggered by various risk factors:

  • Injury to the mucosa.

The mucous tissue that covers the inner surface of the digestive organ is very sensitive to aggressive chemicals, heat and mechanical damage. With prolonged exposure to pathogenic factors, squamous epithelial cells are replaced by other cells that are more resistant to external influences. This replacement is called metaplasia. Experts call the transformation of cells a precancerous condition, regardless of the place of their formation. When replacement cells appear in atypical places in the patient's body, this indicates the occurrence of a malignant tumor. In some cases, it develops rapidly.

  • Chronic disease of the esophagus.

The long course of an inflammatory or chronic disease of the esophagus in a patient entails consequences. Against the background of inflammation, a malignant process can begin. The result of such inflammation can be a small malignant neoplasm. These diseases include: gastroesophageal reflux disease (it leads to tumors of the esophagus and stomach), Barrett's esophagus, achalasia of the esophagus cardia, esophageal hernia. All patients with these diseases should be regularly examined

  • Genetic predisposition.

Science has found a link between the development of esophageal cancer and changes in the p53 gene. A rare genetic abnormality gradually leads to an increased production of an abnormal protein, which normally prevents cells from becoming malignant.

  • Injury to the esophagus, dysfunction of the sphincter between the esophagus and stomach.
  • Factors that increase the overall risk of developing cancer.
  • Human papillomavirus.
  • Alcohol consumption.
  • Thermal and chemical burns of the esophagus.
  • Smoking.
  • Vitamin deficiency.
  • The predominance of very hot, sour and spicy foods in the diet.
  • Frequent heartburn (reflux of gastric juice).

Many of these risk factors act directly on the mucous membrane of the organ through general processes in the patient's body.

Classification of esophageal cancer

  1. Clinical. According to the clinical picture of the development of the disease, it is divided into four stages of development.
    • I stage. A small tumor affects the submucosa and mucous membranes of the walls of the esophagus. It does not disrupt the normal passage of food and does not cause metastases.
    • Stage II. The development of the neoplasm occurs in the wall of the esophagus and reaches the muscle layer. The patient begins to experience discomfort when food passes through the esophagus. There are single metastases of esophageal cancer in closely spaced lymph nodes.
    • Stage III. The disease occupies a large half of the circumference of the esophagus with spread to the walls. Tumor cells begin to penetrate into neighboring tissues, disrupt patency and complicate the movement of food. A fairly large number of metastases appear in regional lymph nodes.
    • Stage IV. Penetration begins - the germination of education in other surrounding organs. Malignant formation can completely close the lumen of the esophagus. In this case, metastases are formed even on distant lymph nodes.
  2. According to the location of the tumor. Esophageal cancer occurs:
    • in the cervical region - cancer of the cervical esophagus;
    • in the chest cavity - cancer of the thoracic esophagus (this type is most common);
    • in the abdominal region - cancer of the abdominal esophagus.
    Depending on the location of the tumor, the patient may experience a variety of symptoms. The classification of esophageal cancer is important for choosing a method for localizing metastases, which may be in surrounding tissues or regional lymph nodes. This is facilitated by the active plexus of blood vessels. It plays a key role in metastasis. Most often, the neoplasm is formed in the thoracic esophagus.
  3. Depending on the type of its growth, esophageal cancer is:
    • exophytic - the tumor grows in the lumen of the esophagus and blocks its patency, filling the internal space;
    • endophytic - the formation grows through the walls of the esophagus, penetrates into the surrounding organs and tissues, putting pressure on the lumen of the esophagus from the outside;
    • mixed type - is quite rare and combines signs of endophytic and exophytic cancer, in this case the tumor grows and progresses very quickly.

The macroscopic form of a cancerous tumor of the esophagus can be:

  • sclerosing;
  • ulcerative;
  • nodal;
  • infiltrative.

The exact type of neoplasm can be determined during an endoscopic examination of the patient. Each type has its own characteristics of manifestation and distribution and affects the choice of treatment method.

Microscopic classification of esophageal cancer is determined by post-mortem examination of the biopsy material.

Types of tumor:

  • carcinosarcoma;
  • adenocarcinoma;
  • squamous cell carcinoma;
  • adenocystic.
  • small cell cancer;
  • mucoepidermoid cancer.

Squamous cell carcinoma of the esophagus is a tumor that originated from squamous cells of the epithelium. Adenocarcinoma is a tumor that arises in secretory (glandular) cells located in the mucosa of the esophagus.

According to the TNM system, where T means the degree of tumor invasion, N is the degree of damage to the lymph nodes, M is the presence of distant metastases, the following stages of esophageal cancer are distinguished:

  • T1 - the tumor occupies the mucous membrane, T2 - grows into the muscle layer, T3 - into the connective tissue layer, T4 - into neighboring organs and tissues;
  • N0 - no metastases in regional lymph nodes, N1 - 1-2 metastases in lymph nodes, N2 - 3-6 metastases, N3 - more than six;
  • M0 - tumor without distant metastases, M1 - distant metastases.

Depending on the established morphological diagnosis, oncologists plan the treatment of esophageal cancer. It also depends on the type of structure and localization of the tumor, which metastasizes to the lymph nodes and organs. The higher the degree of differentiation of cancer cells, the better the clinical prognosis. Cells with a low level of differentiation indicate a serious course of the disease.

How to identify cancer of the esophagus? Symptoms

Esophageal cancer is more favorable in terms of symptoms than other neoplasms of the gastrointestinal tract. In the first stages of the development of a malignant tumor, a person has mild symptoms and discomfort when swallowing food. It is this condition that encourages the patient to consult a doctor for a diagnosis.

Signs of esophageal cancer:

  • impaired passage of food (dysphagia) caused by narrowing of the esophagus;
  • sore throat, cough, hoarseness;
  • discomfort during swallowing;
  • nausea and vomiting;
  • gradual exhaustion of the body, weakness, anemia;
  • belching, heartburn;
  • bad breath;
  • increased salivation;
  • aversion to meat;
  • temperature;
  • weight loss;
  • pain in the projection of the tumor (in the chest, between the shoulder blades, in the area of the solar plexus) - this condition is sometimes confused with angina pectoris, osteochondrosis, deforming spondylosis.

Dysphagia in esophageal cancer is divided into four degrees: 1 - difficulty passing solid food, 2 - soft food, 3 - liquid, 4 - complete obstruction.

When the disease spreads to neighboring organs, the patient begins to show symptoms from their side, such as respiratory failure, local pain and cough.

You need to see a doctor in the earliest stages of cancer. This will allow timely start of cancer treatment and reduce the adverse effects.

Complications of esophageal cancer

  • Pain syndrome. The development of the tumor is accompanied by pain and is difficult to anesthetize. Pain may increase during swallowing.
  • Obstruction of the lumen of the esophagus. The normal movement of food through the esophagus is disrupted, which subsequently leads to the exhaustion of the entire patient's body.
  • Esophagotracheal fistula. This painful canal forms between the trachea and the esophagus. As a result, breathing and digestion are disturbed. During coughing, fragments of food can be found in the sputum.
  • Bleeding. As the neoplasm grows, so does the vascular tissue around it. As decay occurs, the capillaries around the tumor become damaged and bleed.

The above complications appear in the advanced stages of esophageal cancer and require symptomatic treatment.

Diagnosis of esophageal cancer

The doctor conducts a physical examination of the patient, collects an anamnesis, symptoms. At the first suspicion of esophageal cancer, an esophagogastroduodenoscopy (EGDS study) should be performed. Endoscopic diagnosis using a flexible instrument allows the doctor to see the entire esophagus from the inside. In this case, the device can take a fragment of the affected tissue for a deeper clinical study. Based on this, an accurate diagnosis can be made.

To determine the type of esophageal cancer and prescribe the appropriate treatment for the patient, the doctor may use other diagnostic methods:

  • ultrasound diagnostics (ultrasound);
  • computed tomography (CT);
  • magnetic resonance imaging (MRI);
  • transesophageal ultrasound;
  • radiography;
  • bronchoscopy;
  • positron emission tomography (PET).

Research methods make it possible to detect tumor metastases, accurately determine the type and stage of development of esophageal cancer, the degree of damage to the liver, lungs, spinal cord and brain and other organs. They also prescribe tests and laboratory tests, a biopsy. The most complete diagnosis helps to better select the type of cancer treatment that will bring the greatest benefit to the patient.

Esophageal cancer treatment

Modern methods of treating esophageal cancer include the following:

  • Radiotherapy. A tumor can be exposed to radiation that kills its cells. This method for the treatment of esophageal cancer is used in three cases:
    • Radiotherapy as a stand-alone treatment – suitable for the treatment of stage 1-3 squamous cell carcinoma of the esophagus, in which case radiotherapy is used together with chemotherapy (chemoradiotherapy), the treatment is aimed at the tumor and regional metastases;
    • radiotherapy before surgery - in this case, radiotherapy is the first stage of treatment for esophageal cancer, and the goal is to reduce the size of malignant tumors (in this situation, radiotherapy is also used in combination with chemotherapy);
    • Radiotherapy after surgery - sometimes the operated areas are exposed to radiation.

In addition, radiation therapy is widely used where the patient cannot be operated on. And in stage 4 esophageal cancer, it is used as a palliative treatment to shrink the tumor and relieve symptoms.

Radiotherapy has contraindications. These are, for example, perforation of the esophagus, cachexia and some other conditions. Distant metastases can also interfere with the use of radiation therapy. But if metastases are present only in regional lymph nodes, this is usually not a contraindication for radiation therapy. Side effects of radiation therapy are local skin reactions in the places to which the radiation is directed, as well as fatigue, deterioration in blood counts.

  • Surgical treatment (operation). Depending on the type and degree of penetration of the tumor formation into the organ, the method of endoscopic or open surgical intervention can be chosen, i.e. surgery to remove diseased tissue. Surgical treatment is directed both to the organ itself and to the lymph nodes.
  • Chemotherapy. When tumor tissues show sensitivity to chemical attack, doctors prescribe chemotherapy to the patient. Modern drugs quickly destroy tumor tissue and reduce the risk of recurrence. Depending on the nature of the course of the disease, a different number of drugs and many courses can be used. Chemotherapy can also be combined with radiation therapy and other effective cancer treatments. Chemotherapy is used when surgery or radiation therapy is not possible due to contraindications or other reasons. During chemotherapy, drugs such as platinum, taxanes, fluoropyrimidines and others are used.

Stenting of the esophagus, infusion therapy, anesthesia, etc. can also be performed for treatment.

Prognosis after cancer treatment and follow-up of patients

Even the most successful treatment does not remove the seriousness of the diagnosis. Cancer is always dangerous with the occurrence of recurrent pathologies. After effective cancer treatment, it is important to visit the gastroenterologist, treating oncologist and surgeon regularly, as well as conduct diagnostic examinations.

A good prognosis depends on the location of the tumor, the age of the person, the presence of underlying diseases and the duration of the cancer. The stage at which treatment for esophageal cancer is started is important. As a rule, at the very first stage, the survival rate of the patient is 90%, at the second it ranges from 50-70%, and at the third it is only 10-25%. To significantly increase these indicators, it is important for the patient to undergo regular examinations, follow the diet and completely eliminate bad habits.

Our doctors in the K + 31 clinics in Moscow treat patients with esophageal cancer, cancer the liver, small and large intestine, stomach cancer, melanoma sarcoma and other problems from the field of oncology. We carry out diagnostics and treatment, surgical operations, laboratory tests using modern equipment, which allows us to treat patients as efficiently as possible and with minimal side effects. Call us by phone or fill out an application on the website!

Service record



Specialists

All specialists
Merkulov
Igor Alexandrovich

Deputy chief physician for oncology, oncologist

Doctor of Sciences, PhD


Academician, professor, Doctor of Sciences, PhD

Petrov
Dmitry Yurevich

Deputy chief physician for oncology, surgeon

PhD, Docent

Ershova
Ksenia Igorevna

Head of department, oncologist

PhD

Rasner
Pavel Ilyich

Consultant in urology, urologist

Doctor of Sciences, PhD, professor

Malygin
Sergey Evgenyevich

Oncologist-mammologist, surgeon

Pshikhachev
Ahmed Mukhamedovich

Urologist, Oncologist

Doctor of Sciences, PhD

Shevchuk
Alexei Sergeyevich

Oncogynecology consultant, obstetrician-gynecologist

PhD

Chichkanova
Tatyana Vladimirovna

Oncologist-mammologist, radiologist

Katz
Ksenia Vladimirovna

Dermatovenerologist, oncologist

Rakova
Elena Sergeevna

Oncologist, chemotherapist

Udin
Oleg Ivanovich

Deputy chief physician for surgery, surgeon

PhD

Kogonia
Lali Mikhailovna

Chemotherapist

Doctor of Sciences, PhD

Ushenina
Maria Valerievna

Oncologist-chemotherapist

PhD

Stepura
Yulia Evgenievna

Head of the department of antitumor drug therapy, oncologist, chemotherapist

Volkova
Daria Mikhailovna

Head of the radiation therapy department

Gomov
Mikhail Alexandrovich

Consultant in oncogynecology, obstetrician-gynecologist

Grishin
Igor Igorevich

Obstetrician-gynecologist

Doctor of Sciences, PhD, professor

Achba
Maya Otarovna

Radiologist, ultrasound diagnostician, oncologist-mammologist